1. Enhancement of adenovirus infection and adenoviral vector-mediated gene delivery by bromodomain inhibitor JQ1
   Baojie Lv et al, 2018, Sci Rep CrossRef
2. Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma
   Feng Li et al, 2020, Curr Pharmacol Rep CrossRef
3. Oncolytic Viruses as Immunotherapeutic Agents
   Yevhenii Trehub et al, 2021 CrossRef
4. A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
   Zifang Zhang et al, 2020, Cells CrossRef
5. Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use
   Natalia Hernandez-Pacheco et al, 2021, Eur Respir J CrossRef
6. Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
   Annalisa Chianese et al, 2021, Cancers CrossRef
7. Brd4 Inactivation Increases Adenoviral Delivery of BMP2 for Paracrine Stimulation of Osteogenic Differentiation as a Gene Therapeutic Concept to Enhance Bone Healing
   Christopher R Paradise et al, 2021, JBMR Plus CrossRef
8. Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
   Shoh Yajima et al, 2021, Molecular Therapy - Oncolytics CrossRef
9. Gospel of malignant Glioma: Oncolytic virus therapy
   Jinjian Li et al, 2022, Gene CrossRef
10. Histone modifiers at the crossroads of oncolytic and oncogenic viruses
    Sara A. Murphy et al, 2022, Molecular Therapy CrossRef
11. Effects of H101 on proliferation, migration, and apoptosis of gastric cancer cells and underlying mechanisms
    Su Shao et al, 2022, WCJD CrossRef
12. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
    Zhi Zhu et al, 2022, Mol Cancer CrossRef
13. Histone deacetylase inhibitor boosts anticancer potential of fusogenic oncolytic vaccinia virus by enhancing cell–cell fusion
    Motomu Nakatake et al, 2023, Cancer Science CrossRef